|
|
Prepublished online as a Blood First Edition Paper on January 16, 2003; DOI 10.1182/blood-2002-09-2778.
 Previous Article | Table of Contents | Next Article 
Blood, 15 May 2003, Vol. 101, No. 10, pp. 3875-3876
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Brief report
Utility of FDG-PET scanning in lymphoma by WHO
classification
Rebecca Elstrom,
Liang Guan,
Gary Baker,
Khozaim Nakhoda,
Jo-Anne Vergilio,
Hongming Zhuang,
Stephanie Pitsilos,
Adam Bagg,
Lisa Downs,
Amit Mehrotra,
Scott Kim,
Abass Alavi, and
Stephen J. Schuster
From the Abramson Family Cancer Research
Institute of the University of Pennsylvania, Philadelphia; and the
Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and
Pathology, University of Pennsylvania Medical Center, Philadelphia.
We retrospectively evaluated 18fluoro-2-deoxyglucose
positron emission tomography (FDG-PET) scans in 172 patients with
lymphoma and correlated results with pathologic diagnosis using the
World Health Organization (WHO) classification system. In total,
FDG-PET detected disease in at least one site in 161 patients (94%)
and failed to detect disease in 11 patients (6%). The most frequent lymphoma diagnoses were diffuse large B-cell lymphoma (LBCL; n = 51),
Hodgkin lymphoma (HL; n = 47), follicular lymphoma (FL; n = 42),
marginal zone lymphoma (MZL; n = 12), mantle cell lymphoma (MCL;
n = 7), and peripheral T-cell lymphoma (PTCL; n = 5). FDG-PET detected disease in 100% of patients with LBCL and MCL and in 98% of
patients with HL and FL. In contrast, FDG-PET detected disease in only
67% of MZL and 40% of PTCL. Comparison with bone marrow biopsies
showed that FDG-PET was not reliable for detection of bone marrow
involvement in any lymphoma subtype.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Bodet-Milin, F. Kraeber-Bodere, P. Moreau, L. Campion, B. Dupas, and S. Le Gouill
Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma
Haematologica,
March 1, 2008;
93(3):
471 - 472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. C. Kwee, R. M. Kwee, and R. A. J. Nievelstein
Imaging in staging of malignant lymphoma: a systematic review
Blood,
January 15, 2008;
111(2):
504 - 516.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sasaki, N. Shikama, K. Koiwai, and M. Kadoya
Relationship Between the Response to Treatment and the Prognosis of Patients with Aggressive Lymphomas Treated with Chemotherapy Followed by Involved-field Radiotherapy: Radiographic Assessment
Jpn. J. Clin. Oncol.,
January 1, 2008;
38(1):
43 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ansquer, T. Hervouet, A. Devillers, S. de Guibert, T. Gastinne, S. Le Gouill, E. Garin, A. Moreau, F. Kraeber-Bodere, and T. Lamy
18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease
Haematologica,
January 1, 2008;
93(1):
128 - 131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Seam, M. E. Juweid, and B. D. Cheson
The role of FDG-PET scans in patients with lymphoma
Blood,
November 15, 2007;
110(10):
3507 - 3516.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kako, K. Izutsu, Y. Ota, Y. Minatani, M. Sugaya, T. Momose, K. Ohtomo, Y. Kanda, S. Chiba, T. Motokura, et al.
FDG-PET in T-cell and NK-cell neoplasms
Ann. Onc.,
October 1, 2007;
18(10):
1685 - 1690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Juweid, S. Stroobants, O. S. Hoekstra, F. M. Mottaghy, M. Dietlein, A. Guermazi, G. A. Wiseman, L. Kostakoglu, K. Scheidhauer, A. Buck, et al.
Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
J. Clin. Oncol.,
February 10, 2007;
25(5):
571 - 578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Cheson, B. Pfistner, M. E. Juweid, R. D. Gascoyne, L. Specht, S. J. Horning, B. Coiffier, R. I. Fisher, A. Hagenbeek, E. Zucca, et al.
Revised Response Criteria for Malignant Lymphoma
J. Clin. Oncol.,
February 10, 2007;
25(5):
579 - 586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Reiter
Diagnosis and Treatment of Childhood Non-Hodgkin Lymphoma
Hematology,
January 1, 2007;
2007(1):
285 - 296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Venugopal and S. A. Gregory
Lymphoproliferative disorders
ASH Self-Assessment Program,
January 1, 2007;
2007(1):
265 - 297.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. L. Kasamon, R. J. Jones, and R. L. Wahl
Integrating PET and PET/CT into the Risk-Adapted Therapy of Lymphoma
J. Nucl. Med.,
January 1, 2007;
48(1_suppl):
19S - 27S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. S. Jhanwar and D. J. Straus
The Role of PET in Lymphoma
J. Nucl. Med.,
August 1, 2006;
47(8):
1326 - 1334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Y. Tsai, A. Taur, L. Espinosa, A. Quon, D. Johnson, S. Dick, S. Chow, R. Advani, R. Warnke, S. Kohler, et al.
Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.
Arch Dermatol,
May 1, 2006;
142(5):
577 - 584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Wohrer, U. Jaeger, K. Kletter, A. Becherer, A. Hauswirth, K. Turetschek, M. Raderer, and M. Hoffmann
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading
Ann. Onc.,
May 1, 2006;
17(5):
780 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Juweid and B. D. Cheson
Positron-Emission Tomography and Assessment of Cancer Therapy
N. Engl. J. Med.,
February 2, 2006;
354(5):
496 - 507.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Juweid
Utility of Positron Emission Tomography (PET) Scanning in Managing Patients with Hodgkin Lymphoma
Hematology,
January 1, 2006;
2006(1):
259 - 265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Hollister Jr, M. S. Lee, R. N. Eisen, C. Fey, and C. S. Portlock
Variable Problems in Lymphomas: CASE 2. Sarcoidosis Mimicking Progressive Lymphoma
J. Clin. Oncol.,
November 1, 2005;
23(31):
8113 - 8116.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Schoder, A. Noy, M. Gonen, L. Weng, D. Green, Y. E. Erdi, S. M. Larson, and H. W.D. Yeung
Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin's Lymphoma
J. Clin. Oncol.,
July 20, 2005;
23(21):
4643 - 4651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. E. Pakos, A. D. Fotopoulos, and J. P.A. Ioannidis
18F-FDG PET for Evaluation of Bone Marrow Infiltration in Staging of Lymphoma: A Meta-Analysis
J. Nucl. Med.,
June 1, 2005;
46(6):
958 - 963.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al.
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Clin. Cancer Res.,
April 15, 2005;
11(8):
2785 - 2808.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. P. Beal, H. W. Yeung, and J. Yahalom
FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases
Ann. Onc.,
March 1, 2005;
16(3):
473 - 480.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kazama, S. C. Faria, V. Varavithya, S. Phongkitkarun, H. Ito, and H. A. Macapinlac
FDG PET in the Evaluation of Treatment for Lymphoma: Clinical Usefulness and Pitfalls
RadioGraphics,
January 1, 2005;
25(1):
191 - 207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Thompson and C. B. Thompson
Putting the Rap on Akt
J. Clin. Oncol.,
October 15, 2004;
22(20):
4217 - 4226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Elstrom, D. E. Bauer, M. Buzzai, R. Karnauskas, M. H. Harris, D. R. Plas, H. Zhuang, R. M. Cinalli, A. Alavi, C. M. Rudin, et al.
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Cancer Res.,
June 1, 2004;
64(11):
3892 - 3899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Meyer, R. F. Ambinder, and S. Stroobants
Hodgkin's Lymphoma: Evolving Concepts with Implications for Practice
Hematology,
January 1, 2004;
2004(1):
184 - 202.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Friedberg and V. Chengazi
PET Scans in the Staging of Lymphoma: Current Status
Oncologist,
October 1, 2003;
8(5):
438 - 447.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
